Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Fathi Mazouz is active.

Publication


Featured researches published by Fathi Mazouz.


European Journal of Medicinal Chemistry | 1990

5-Aryl-1,3,4-oxadiazol-2(3H)-one derivatives and sulfur analogues as new selective and competitive monoamine oxidase type B inhibitors

Fathi Mazouz; Luc Lebreton; René Milcent; Claude Burstein

Eighteen new 5-aryl-1,3,4-oxadiazol-2(3H)-one derivatives and sulfur analogues were prepared and evaluated in vitro for their inhibitory properties on monoamine oxidase (MAO) types A and B. The most active compounds in these series acted preferentially against MAO B with IC50 values in the range of 1.8-0.056 μM. The 5-(4-biphenylyl)-3-(2-cyanoethyl)-1,3,4-oxadiazol-2(3H)-one 23 and its oxadiazolethione analogue 33 were found to act as potent, selective and competitive MAO B inhibitors with a slight slow-binding character. Both compounds inhibited MAO A in a classical competitive manner. According to their Ki (MAO B) values of 2.6 and 4 × 10−8 M, respectively, and their Ki (MAO A)/Ki (MAO B) ratios of 270 and 500, respectively, 23 and 33 can be placed among the most active and selective competitive MAO B inhibitors known up to now. The structure-activity relationships are discussed.


European Journal of Medicinal Chemistry | 1988

Inhibition of monoamine oxidase types A and B by 2-aryl-4H-1,3,4-oxadiazin-5(6H)-one derivatives

Fathi Mazouz; Luc Lebreton; René Milcent; Claude Burstein

Abstract Monoamine oxidase (MAO) assay specificity based on substrate specificity was investigated by substrate competition experiments. 10 μM serotonin (5-HT) and 5 μM β-phenylethylamine (PEA) were found to ensure total substrate specificity for, respectively, MAO types A and B. Twenty-five 2-aryl-4 H -1,3,4-oxadiazin-5(6 H )-one derivatives were synthesized and tested in vitro for their inhibitory effects on MAO A and B. Most of them inhibited preferentially MAO B. The 2-(4-biphenylyl)-4-(2-cyanoethyl)-4 H -1,3,4-oxadiazin-5(6 H )-one 32 was the most efficient MAO B inhibitor and acted as a competitive inhibitor on the two enzymes. Its K i values for MAO A and B were 11 and 0.15 μM, respectively. Structure-activity relationships suggest that these oxadiazinones should interact with a hydrophobic site and a nucleophilic site on MAO B for binding, while the functional group of the N-4 substituent should compete with the substrate for the active site of the enzyme.


Journal of Medicinal Chemistry | 1993

5-[4-(benzyloxy)phenyl]-1,3,4-oxadiazol-2(3H)-one derivatives and related analogues: new reversible, highly potent, and selective monamine oxidase type B inhibitors.

Fathi Mazouz; Salah Gueddari; Claude Burstein; Daniel Mansuy; René Milcent


Journal of Medicinal Chemistry | 1995

Selective and potent monoamine oxidase type B inhibitors: 2-substituted 5-aryltetrazole derivatives.

Luc Lebreton; Olivier Curet; Salah Gueddari; Fathi Mazouz; Suzanne Bernard; Claude Burstein; René Milcent


Journal of Heterocyclic Chemistry | 1991

Ring transformations of 1,3,4-oxadiazol-2(3H)-one derivatives into 1-amino and 1,3-diamino-2,4-imidazolidinedione (hydantoin) derivatives

René Milcent; Géo Barbier; Beatrice Yver; Fathi Mazouz


European Journal of Medicinal Chemistry | 1990

Dérivés d'aryl-5 3H-oxadiazone-1,3,4 ones-5 et d'analogues soufrés comme nouveaux inhibiteurs sélectifs et compétitifs de la monoamine oxydase B

Fathi Mazouz


Archive | 1989

(Hetero)aryl-diazole derivatives, process for their preparation and their therapeutical use

René Milcent; Luc Lebreton; Fathi Mazouz; Claude Burstein; Salah Gueddari


Archive | 1989

ARYL SUBSTITUTED TETRAZOLE DERIVATIVES, AND APPLICATION THEREOF IN THERAPEUTICS

René Milcent; Luc Lebreton; Fathi Mazouz; Claude Burstein; Salah Gueddari


Archive | 1992

New (hetero)aryl substituted diazole derivatives, the method of preparing them and application thereof in therapeutics

René Milcent; Luc Lebreton; Fathi Mazouz; Claude Burstein; Salah Gueddari


Archive | 1988

New derivatives of tetrahydro-1,4,5,6 tetrazine-1,2,4,5 one-3, process for the production and application of the stable radicals which constitute the dehydrogenated form as contrast agents in nuclear magnetic resonance

René Milcent; Géo Barbier; Fathi Mazouz; Aziza Khaled Ben

Collaboration


Dive into the Fathi Mazouz's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Daniel Mansuy

Paris Descartes University

View shared research outputs
Researchain Logo
Decentralizing Knowledge